Metastatic Hormone-Sensitive Prostate Cancer (mHSPC): Advances and Treatment Strategies in the First-Line Setting
Abstract The treatment landscape of metastatic hormone-sensitive prostate cancer (mHSPC) has changed radically in recent years. Androgen deprivation therapy (ADT) alone was for decades the standard of care for treating mHSPC. This changed when studies showed that the addition of docetaxel chemothera...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Adis, Springer Healthcare
2020-06-01
|
| Col·lecció: | Oncology and Therapy |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1007/s40487-020-00119-z |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|